Ticker League

EBITDA for MetLife (MET)

Latest filings through · Reported

Metric

TTM

$5.88B

YoY change

-22.4%

5Y CAGR

-7.5%

Peak year (2011)

$11.59B

EBITDA history chart for MetLife (MET) from 1995 to 2025

Latest: $5.72B

EBITDA growth chart for MetLife (MET) from 1995 to 2025

Latest: -22.4%

EBITDA history table for MetLife (MET) from 1995 to 2025

  • 2025$5.72B-22.4%
  • 2024$7.37B+87.8%
  • 2023$3.92B-50.8%
  • 2022$7.97B-21.3%
  • 2021$10.13B+19.8%
  • 2020$8.46B+0.9%
  • 2019$8.38B+4.0%
  • 2018$8.06B+47.6%
  • 2017$5.46B-10.3%
  • 2016$6.09B-18.9%
  • 2015$7.51B-30.0%
  • 2014$10.73B+77.5%
  • 2013$6.05B+78.2%
  • 2012$3.39B-70.7%
  • 2011$11.59B+93.1%
  • 2010$6.00B-304.3%
  • 2009−$2.94B-147.7%
  • 2008$6.16B-9.7%
  • 2007$6.82B+39.2%
  • 2006$4.90B-7.7%
  • 2005$5.30B+23.2%
  • 2004$4.30B+30.4%
  • 2003$3.30B+43.1%
  • 2002$2.31B+79.3%
  • 2001$1.29B+16.1%
  • 2000$1.11B+5.9%
  • 1999$1.05B-47.0%
  • 1998$1.98B+67.1%
  • 1997$1.18B-11.5%
  • 1996$1.33B+20.7%
  • 1995$1.11B—

EBITDA values are taken from MetLife's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA at MetLife (MET)

According to MetLife's latest reported financial statements, the company's current EBITDA (TTM) is $5.88B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

MetLife (MET) most recent annual EBITDA stands at $5.72B (2025) – declined 22.4% year-over-year.

MetLife EBITDA compound annual growth for the 2020–2025 (5 years) window is -7.5%, with a net decline across the window.

MetLife EBITDA peaked at $11.59B in 2011; the latest annual figure is $5.72B in 2025 (50.6% below peak).

$11.59B stands as the all-time-high annual EBITDA, posted in 2011, against a low of −$2.94B during 2009.

MetLife EBITDA by Year

MetLife EBITDA 2025: $5.72B

MetLife posted EBITDA of $5.72B in 2025, declined 22.4% below 2024.

MetLife EBITDA 2024: $7.37B

In 2024, MetLife reported EBITDA of $7.37B, surged 87.8% from 2023.

MetLife EBITDA 2023: $3.92B

MetLife EBITDA in 2023 was $3.92B, plunged 50.8% below 2022.

MetLife EBITDA 2022: $7.97B

2022's EBITDA for MetLife came in at $7.97B, declined 21.3% below 2021.

MetLife EBITDA 2021: $10.13B

MetLife EBITDA in 2021 was $10.13B.

See more financial history for MetLife (MET).

Sector peers by EBITDA

Financial Services peers of MetLife (MET), ranked by their latest EBITDA

Frequently asked questions

MetLife (MET) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview